Vice President API MSAT QC in CMC & Product Supply, Kalundborg (Denmark)

Vice President API MSAT Quality Control in CMC & Product Supply, Kalundborg (Denmark)

 

Are you an experienced leader of large-scale quality control organisations in technically complex lab and analytical settings? Can you combine strategic vision with hands‑on execution to drive innovation, operational excellence, and uncompromising API quality control? If so, we invite you to join Novo Nordisk as our new Vice President of Quality Control (QC) within Active Pharmaceutical Ingredient (API) Manufacturing Science & Technology (MSAT). Read on and apply today to make an indispensable difference in the consistent, high-quality production of our life-saving medicines.

 

The position
As the Vice President of Quality Control, you will assume leadership over critical aspects of our Active Pharmaceutical Ingredient (API) manufacturing pipeline. This role demands a strong focus on compliance, process mastery, and future-proofing our operations through advanced technol-ogy adoption.

 

Quality control (QC) within API MSAT is a newly created organisation consisting of four Director-led areas with 330 highly qualified lab technicians and professionals based in several facilitates in Kalundborg, Denmark. The task is to centralise the new organisation under the new leadership and ensure one smooth operation capable of handling the ever-increasing demands of a growing organisation and evolving pipeline.

 

In this high-impact role, you will:

• Oversee API Quality Control: Lead and manage API quality control operations, ensuring unwavering compliance with all internal standards, international cGMP, and regulatory requirements.
• Drive Operational Excellence: Champion, innovate and implement process improvement initiatives to strategically optimize manufacturing efficiency, reduce costs, and enhance production scheduling across the API portfolio.
• Strategic Leadership: Develop and implement critical strategic priorities that are tightly aligned with Novo Nordisk’s overall global objectives and growth projections.
• Champion Innovation: Drive sustainable and best-in-class manufacturing practices and accelerate the implementation of cutting-edge closed and continuous automation sys-tems.
• Executive Representation: Represent the API quality control cluster in strategic decision-making forums, ensuring quality and compliance priorities are central to business strate-gy.
• Develop Talent: Lead and mentor large, cross-functional teams, fostering robust collabo-ration, professional growth, and technical mastery.

 

The role is based in Kalundborg, Denmark.

 

Qualifications

We are looking for an experienced and innovative leader with a proven track record of success in managing complex, compliant manufacturing environments.

 

The successful candidate will possess:

• Extensive Leadership Experience: Minimum of 10 years of leadership experience (includ-ing leading leaders), ideally within Quality Control for API manufacturing, biochemical production, or a highly regulated pharmaceutical/biotech environmen t.
• Technical Mastery: Deep expertise in cGMP regulations, quality control operations, and analytical science, particularly in scaling and optimizing API processes.
• Change Leadership: Proven ability to lead large, geographically dispersed teams in a ma-trix organisation and drive innovation, process improvement and technology adoption ini-tiatives.
• M.Sc. or Ph.D. in Chemical Engineering, Biotechnology, Process Science, or a related field.

 

About the organisation

Active Pharmaceutical Ingredient (API) Manufacturing Science & Technology (MSAT) is a depart-ment within Novo Nordisk’s Product Supply organisation. The department is at the forefront of bridging clinical development and manufacturing at Novo Nordisk. Our mission is to support the present and future manufacturing of Active Pharmaceutical Ingredients (APIs) through:

 

• Developing and maintaining robust quality control and analysis for all marketed APIs.
• Providing expert support to production in process and analytical methods.
• Driving process optimizations to enhance capacity and efficiency to meet unprecedented global demand.
• Pioneering the development and implementation of new technologies, ensuring we move toward closed and continuous processes.